For Immediate Release: May 23, 2019
The Huntington Study Group (HSG) is excited to announce that the spring 2019 edition (Vol. 21) of HD Insights is now available in print and online. The spring edition includes a cover story on antisense oligonucleotides, feature stories on Right to Try policy and infusion therapies, a look at new research, plus an update from past Shoulson Scholar Fund recipients.
HD Insights is a semi-annual publication that highlights the latest research on Huntington disease. HD Insights provides readers with information about the most recent scientific findings and clinical trials that are underway, and introduces them to the individuals and companies who are working diligently to pursue therapies and even a cure for HD.
To view the spring edition online, follow either of the web addresses below:
If you would like copies of the printed edition for your institution, organization, or office, please contact email@example.com to arrange.
Founded in 1993 in Rochester, NY, the Huntington Study Group (HSG) is a not-for-profit organization comprised of the world’s first and largest collaborative network of experts in Huntington disease. The mission of the HSG is seeking treatments that make a difference for those affected by HD. With more than 650 credentialed HD experts at 122 HSG credentialed research sites worldwide, the HSG is a leader in conducting clinical trials for HD. The HSG also offers educational services like CME4HD ™ for healthcare professionals and care providers on treating patients with HD. For more information, visit our website www.huntingtonstudygroup.org.